Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China
· Delayed Price · Currency is CNY 91.47
+1.46 (1.62%)
Aug 15, 2025, 3:00 PM CST
SHA:688578 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 14, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Market Capitalization | 41,162 | 26,955 | 18,747 | 8,856 | 13,590 | 12,816 | Upgrade
|
| Market Cap Growth | 83.56% | 43.78% | 111.69% | -34.83% | 6.04% | - | Upgrade
|
| Enterprise Value | 37,517 | 23,927 | 16,494 | 6,916 | 11,015 | 12,083 | Upgrade
|
| Last Close Price | 91.47 | 59.66 | 40.98 | 19.36 | 29.71 | 28.02 | Upgrade
|
| PE Ratio | 26.82 | 18.85 | 29.10 | 67.85 | 743.66 | - | Upgrade
|
| Forward PE | 23.05 | 83.59 | 83.59 | 74.26 | 109.82 | - | Upgrade
|
| PS Ratio | 10.52 | 7.58 | 9.29 | 11.20 | 25.64 | 22849.52 | Upgrade
|
| PB Ratio | 7.30 | 5.10 | 4.71 | 2.78 | 4.57 | 4.45 | Upgrade
|
| P/TBV Ratio | 7.39 | 5.17 | 4.79 | 2.84 | 4.68 | 4.56 | Upgrade
|
| P/FCF Ratio | 31.36 | 20.80 | 30.90 | - | - | - | Upgrade
|
| P/OCF Ratio | 25.83 | 17.21 | 27.79 | 96.65 | 463.96 | - | Upgrade
|
| EV/Sales Ratio | 9.59 | 6.73 | 8.17 | 8.74 | 20.78 | 21543.30 | Upgrade
|
| EV/EBITDA Ratio | 22.40 | 15.83 | 28.12 | 117.62 | - | - | Upgrade
|
| EV/EBIT Ratio | 22.93 | 16.22 | 30.01 | 179.00 | - | - | Upgrade
|
| EV/FCF Ratio | 28.59 | 18.47 | 27.18 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0 | 0 | 0.00 | 0.00 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.00 | 0.00 | 0.03 | - | - | Upgrade
|
| Debt / FCF Ratio | 0.00 | 0.00 | 0.00 | - | - | - | Upgrade
|
| Asset Turnover | 0.72 | 0.69 | 0.52 | 0.24 | 0.17 | 0 | Upgrade
|
| Inventory Turnover | 4.52 | 3.62 | 2.32 | 1.78 | 1.90 | 0.03 | Upgrade
|
| Quick Ratio | 6.99 | 6.73 | 7.18 | 8.62 | 14.59 | 23.80 | Upgrade
|
| Current Ratio | 7.80 | 6.96 | 7.46 | 8.98 | 15.21 | 24.58 | Upgrade
|
| Return on Equity (ROE) | 30.81% | 30.86% | 17.97% | 4.24% | 0.63% | -15.29% | Upgrade
|
| Return on Assets (ROA) | 18.70% | 17.92% | 8.79% | 0.73% | -1.43% | -10.48% | Upgrade
|
| Return on Capital (ROIC) | 20.53% | 19.90% | 9.58% | 0.78% | -1.49% | -10.84% | Upgrade
|
| Return on Capital Employed (ROCE) | 28.90% | 27.80% | 13.80% | 1.20% | - | - | Upgrade
|
| Earnings Yield | 3.73% | 5.30% | 3.44% | 1.47% | 0.13% | -2.42% | Upgrade
|
| FCF Yield | 3.19% | 4.81% | 3.24% | -0.59% | -1.20% | -2.23% | Upgrade
|
| Dividend Yield | 0.87% | 1.09% | 0.98% | - | - | - | Upgrade
|
| Payout Ratio | 19.06% | 20.46% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | 0.91% | 0.18% | -0.09% | 1.49% | -23.59% | -2.30% | Upgrade
|
| Total Shareholder Return | 1.79% | 1.27% | 0.89% | 1.49% | -23.59% | -2.30% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.